FI875324A - Hybridproteiner. - Google Patents

Hybridproteiner. Download PDF

Info

Publication number
FI875324A
FI875324A FI875324A FI875324A FI875324A FI 875324 A FI875324 A FI 875324A FI 875324 A FI875324 A FI 875324A FI 875324 A FI875324 A FI 875324A FI 875324 A FI875324 A FI 875324A
Authority
FI
Finland
Prior art keywords
human
amino acid
subsequences
plasminogen activators
glycosylation
Prior art date
Application number
FI875324A
Other languages
English (en)
Other versions
FI100106B (fi
FI875324A0 (fi
Inventor
Bhanu Rajput
Bhabatosh Chaudhuri
Fredericus Alphonsu Asselbergs
Bernd Meyhack
Jutta Heim
Oostrum Jan Van
Sefik Alkan
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868629153A external-priority patent/GB8629153D0/en
Priority claimed from GB878709656A external-priority patent/GB8709656D0/en
Priority claimed from GB878715890A external-priority patent/GB8715890D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI875324A0 publication Critical patent/FI875324A0/fi
Publication of FI875324A publication Critical patent/FI875324A/fi
Application granted granted Critical
Publication of FI100106B publication Critical patent/FI100106B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Amplifiers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
FI875324A 1986-12-05 1987-12-02 Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi FI100106B (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB868629153A GB8629153D0 (en) 1986-12-05 1986-12-05 Hybrid proteins
GB878701160A GB8701160D0 (en) 1986-12-05 1987-01-20 Hybrid proteins
GB878709656A GB8709656D0 (en) 1986-12-05 1987-04-23 Hybrid proteins
GB878715890A GB8715890D0 (en) 1986-12-05 1987-07-06 Hybrid proteins
GB8629153 1987-07-06
GB8701160 1987-07-06
GB8709656 1987-07-06
GB8715890 1987-07-06

Publications (3)

Publication Number Publication Date
FI875324A0 FI875324A0 (fi) 1987-12-02
FI875324A true FI875324A (fi) 1988-06-06
FI100106B FI100106B (fi) 1997-09-30

Family

ID=27449853

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875324A FI100106B (fi) 1986-12-05 1987-12-02 Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi

Country Status (17)

Country Link
EP (1) EP0277313B1 (fi)
JP (2) JP2641875B2 (fi)
AT (1) ATE148167T1 (fi)
AU (1) AU621281B2 (fi)
CA (1) CA1341479C (fi)
CY (1) CY2156B1 (fi)
DE (1) DE3752008T2 (fi)
DK (1) DK175483B1 (fi)
ES (1) ES2095825T3 (fi)
FI (1) FI100106B (fi)
GR (1) GR3023047T3 (fi)
HK (1) HK1005037A1 (fi)
IE (1) IE81116B1 (fi)
IL (1) IL84700A (fi)
NO (1) NO177603C (fi)
NZ (1) NZ222793A (fi)
PT (1) PT86276B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204255A (en) * 1986-01-31 1993-04-20 Sagami Chemical Research Center Hybrid tissue plasminogen activator/urokinase polypeptides
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
FR2637600B1 (fr) * 1988-10-11 1992-03-06 Pasteur Institut Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques
DE68922859T2 (de) * 1988-10-27 1995-09-21 Tno Trombolytischer wirkstoff mit modifikation der domäne der kringle.
GB8826975D0 (en) * 1988-11-18 1988-12-21 Beecham Group Plc Novel compounds
DE3923339A1 (de) * 1989-05-31 1990-12-06 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator-derivat
IE901849A1 (en) * 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
GB8919803D0 (en) * 1989-09-01 1989-10-18 Ciba Geigy Pharmaceutical compositions
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
EP0462651A1 (en) * 1990-06-15 1991-12-27 Leuven Research & Development V.Z.W. Chimeric plasminogen activators
ATE157703T1 (de) * 1991-12-16 1997-09-15 Ciba Geigy Ag Endoplasmatisches retikulum-ständige rekombinante dibasische endoprotease und deren verwendungen
JPH07143877A (ja) * 1993-10-01 1995-06-06 Sumitomo Pharmaceut Co Ltd 新規なｔ−ＰＡ類似体
TW517059B (en) 1994-07-25 2003-01-11 Ciba Geigy Ag New process for the production of biologically active protein
ES2400306T3 (es) * 2005-10-21 2013-04-09 Catalyst Biosciences, Inc. Proteasas modificadas que inhiben la activación del complemento
SG10201503055TA (en) 2006-07-05 2015-06-29 Catalyst Biosciences Inc Protease screening methods and proteases identified thereby

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
ES2043610T3 (es) * 1986-01-31 1994-01-01 Sagami Chem Res Procedimiento para la produccion de un polipeptido hibrido del tipo activador de plasminogeno.

Also Published As

Publication number Publication date
IL84700A (en) 1992-11-15
ATE148167T1 (de) 1997-02-15
NZ222793A (en) 1990-09-26
AU8209187A (en) 1988-06-16
NO177603C (no) 1995-10-18
JP2641875B2 (ja) 1997-08-20
NO177603B (no) 1995-07-10
CY2156B1 (en) 2002-08-23
DK638187D0 (da) 1987-12-04
ES2095825T3 (es) 1997-03-01
JP2645237B2 (ja) 1997-08-25
JPS63160581A (ja) 1988-07-04
IE81116B1 (en) 2000-03-22
HK1005037A1 (en) 1998-12-18
PT86276B (pt) 1990-11-07
NO875069D0 (no) 1987-12-04
EP0277313B1 (en) 1997-01-22
DE3752008D1 (de) 1997-03-06
PT86276A (en) 1988-06-01
AU621281B2 (en) 1992-03-12
GR3023047T3 (en) 1997-07-30
NO875069L (no) 1988-06-06
IE873299L (en) 1988-06-05
DK175483B1 (da) 2004-11-08
DE3752008T2 (de) 1997-08-14
CA1341479C (en) 2005-04-12
IL84700A0 (en) 1988-05-31
FI100106B (fi) 1997-09-30
DK638187A (da) 1988-06-06
FI875324A0 (fi) 1987-12-02
EP0277313A1 (en) 1988-08-10
JPH09117292A (ja) 1997-05-06

Similar Documents

Publication Publication Date Title
FI875324A (fi) Hybridproteiner.
DE68929551D1 (de) Menschliche DNase
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
NO872988L (no) Pattedyr-interleukin-4.
FI864654A (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
FI103987B1 (fi) Interleukiini-7
ATE142264T1 (de) Rekombinante herstellung von a-ketten- polypeptiden von pdgf
MX168507B (es) Procedimiento para la produccion de proteinas
FI945877A (fi) Menetelmä proteiini C:n tuottamiseksi
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.
ATE110112T1 (de) Verfahren und systeme zur herstellung von hiv- antigenen.

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG

MA Patent expired